FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells

Epithelial Mesenchymal Transition in Tumor Metastasis

(2018) Vivek Mittal   Annual Review of Pathology-Mechanisms of Disease

Emerging roles and mechanisms of FOXC2 in cancer

(2018) Teng Wang et al.   CLINICA CHIMICA ACTA

ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC

(2017) Darina Lazarova et al.   Journal of Cancer

Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression

(2016) Wei Jiang et al.   BMC CANCER

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer

(2016) D.A. Fennell et al.   CANCER TREATMENT REVIEWS

Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo

(2016) Chanjuan Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties

(2016) A N Paranjape et al.   ONCOGENE

Prognostic significance of epithelial–mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast

(2015) Jeffrey Chun Tatt Lim et al.   BREAST CANCER RESEARCH AND TREATMENT

FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition

(2015) Zhijiao Zhou et al.   CANCER LETTERS

FOXF2 suppresses the FOXC2-mediated epithelial–mesenchymal transition and multidrug resistance of basal-like breast cancer

(2015) Jun Cai et al.   CANCER LETTERS

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

(2015) Kari R. Fischer et al.   NATURE

FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways

(2014) Yan-Mei Cui et al.   CANCER LETTERS

Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells

(2014) Zong-cai Liu et al.   CELL AND TISSUE RESEARCH

SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell

(2014) Hao Liu et al.   CELLULAR SIGNALLING

FOXC2 promotes colorectal cancer metastasis by directly targeting MET

(2014) Y-M Cui et al.   ONCOGENE

Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

(2014) Hua Sui et al.   Oncology Research and Treatment

FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer

(2013) B. G. Hollier et al.   CANCER RESEARCH

Acquisition of epithelial–mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway

(2013) Hao Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer

(2013) Hao Wang et al.   PLoS One

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

(2012) Alexandria M Haslehurst et al.   BMC CANCER

EMT in breast cancer stem cell generation

(2012) Stéphane Ansieau   CANCER LETTERS

Gene Expression of Mesenchyme Forkhead 1 (FOXC2) Significantly Correlates With the Degree of Lymph Node Metastasis in Colorectal Cancer

(2012) Toshiaki Watanabe et al.   INTERNATIONAL SURGERY

Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line

(2012) Jin Ren et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol

(2012) Y-H Yu et al.   ONCOGENE

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer

(2012) Fariz Nurwidya et al.   Cancer Research and Treatment

Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

(2011) L. Rosano et al.   CLINICAL CANCER RESEARCH

Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non–Small-Cell Lung Cancer After Curative Resection

(2011) Wei Jiang et al.   Clinical Lung Cancer

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

(2007) Matthew D. Hall et al.   Annual Review of Pharmacology and Toxicology